James C. Czirr - 12 Jan 2022 Form 5 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director, 10%+ Owner
Signature
/s/ James C. Czirr
Issuer symbol
GALT
Transactions as of
12 Jan 2022
Net transactions value
+$12,000
Form type
5
Filing time
01 Dec 2023, 16:50:50 UTC
Next filing
25 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Gift -4,500 -0.59% 760,616 12 Jan 2022 Direct F1
transaction GALT Common Stock Gift -4,500 -0.59% 760,616 12 Jan 2022 Direct F1
transaction GALT Common Stock Gift -4,500 -0.59% 760,616 12 Jan 2022 Direct F1
transaction GALT Common Stock Other $6,000 +1,000 +0.13% $6.00 760,616 31 Mar 2022 Direct F2, F3
transaction GALT Common Stock Other $6,000 +1,000 +0.13% $6.00 760,616 30 Sep 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares transferred to child as a gift. Transaction does not constitute a sale pursuant to Rule 16a-5.
F2 Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividends were payable on 3/31/2020 and 9/30/2020. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
F3 Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9.